Detailed Information on Publication Record
2005
Investigation of osteoprotegerin interactions with ligands and antibodies using piezoelectric biosensors
SKLÁDAL, Petr, Zuzana JÍLKOVÁ, Ivan SVOBODA and Vladimír KOLÁŘBasic information
Original name
Investigation of osteoprotegerin interactions with ligands and antibodies using piezoelectric biosensors
Name in Czech
Studium interakcí osteoprotegerinu s ligandy a protilátkami pomocí piezoelektrických biosensor
Authors
SKLÁDAL, Petr (203 Czech Republic, guarantor), Zuzana JÍLKOVÁ (203 Czech Republic), Ivan SVOBODA (203 Czech Republic) and Vladimír KOLÁŘ (203 Czech Republic)
Edition
Biosensors & Bioelectronics, Oxford, Elsevier Advanced Technology, 2005, 0956-5663
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10600 1.6 Biological sciences
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 3.463
RIV identification code
RIV/00216224:14310/05:00013670
Organization unit
Faculty of Science
UT WoS
000227845700018
Keywords in English
Immunosensor; Quartz crystal microbalance; Serum; Immunoassay
Změněno: 7/6/2005 16:05, prof. RNDr. Petr Skládal, CSc.
V originále
Osteoprotegerin (OPG, osteoclastogenesis inhibitory factor) is a secretory glycoprotein involved as a soluble factor in the regulation of bone mass. OPG and its ligand (RANKL) levels in serum indicate the osteoclast formation activity. Alterations of the RANKL/OPG concentration ratio may be the cause of bone loss in many imbalances including osteoporosis, hypercalcaemia, metastatic osteolytic lesions and rheumatic bone degradation. The interactions of OPG with several antibodies were studied using the piezoelectric quartz crystal sensor. Monoclonal anti-OPG antibodies (5H3, 4E6H9 and OPG1.3) were immobilised on the sensing surface modified with covalently attached monolayer of protein A. Binding of both OPG standard and recombinant OPGFc chimeric protein was followed in real time. All antibodies were able to bind OPG and OPGFc, though in the case of MAb 4E6H9 the immunocomplexes dissociated quickly in the absence of OPG. Alternatively, biorecognition layers with RANKL were used. Two versions of the piezoelectric sensor for OPG were developed. The direct immunosensor was based on the antibody 5H3 and the affinity sensor employed the immobilised RANKL. The RANKL sensor exhibited poor reproducibility of results. For the immunosensor, the measuring range was 1.235 U/L of OPG. One analysis was completed within 15 min; the sensors were used repeatedly using regeneration with glycine buffer (pH 2.0). The developed immunosensor seems promising for rapid determination of osteoprotegerin in serum.
In Czech
Osteoprotegerin (OPG) - regulaní faktor metabolismu kostí byl studován pomocí piezoelektrického biosensoru. Byly charakterisovány jeho interakce s RANKL a nkolika anti OPG monoklonálními protilátkami. Nakonec bylo vyvinuto imunosensorové stanovení této látky v séru a stanovena kalibracní závislost.
Links
MSM0021622413, plan (intention) |
|